Vitalsource Technologies, Inc. Defining Optimal Immunotherapies For Type 1 Diabetes: | Kaicus USA
All categories
Kaicus
Animals & Pet Supplies
Arts & Entertainment
Baby & Toddler
Business & Industrial
Cameras & Optics
Clothing & Accessories
Electronics
Food, Beverages & Tobacco
Furniture
Hardware
Health & Beauty
Home & Garden
Luggage & Bags
Mature
Media
Office Supplies
Software
Sporting Goods
Toys & Games
Vehicles & Parts
UK España Italia Deutschland France
© 2026, Kaicus - Smart Shopping
All rights reserved
Kaicus Vitalsource Technologies, Inc. Defining Optimal Immunotherapies For Type 1 Diabetes: Novartis Foundati
product image
product image

Vitalsource Technologies, Inc. Defining Optimal Immunotherapies For Type 1 Diabetes: Novartis Foundati

170.00 USD

Brand: John Wiley & Sons
Sponsored  This site contains affiliate links for which we may receive compensation. More information

Sponsored Vitalsource Technologies, Inc. Defining Optimal Immunotherapies For Type 1 Diabetes: Novartis Foundati

170.00 USD 170.00 USD
13-11-2024 15:37:33
Access to the deal

Related products

Vitalsource Technologies, Inc. Software Defined Radio

175.00 USD
View Product

Vitalsource Technologies, Inc. The Innovative Company: An Ill-defined Object

142.00 USD
View Product

Vitalsource Technologies, Inc. Software Defined Radio

144.00 USD
View Product

VMware Policy-Driven Software-Defined Storage Guide

36.00 USD
View Product